PeptideStack
5.2kquestions
20kanswers
220users

What is the reported incidence of fatigue on tirzepatide in SURPASS-2?

Asked 24 Apr 2026Modified 9 days agoViewed 8.2k times
24

The particulars: fatigue · tirzepatide · SURPASS-2.

I have the document in front of me and I can read the numbers. What I cannot do is interpret them.

I am reasonably comfortable with statistics and completely uncomfortable with chromatography, or vice versa.

Which parts of this are informative and which are decoration?

fatigue
fatigue

Tiredness on treatment: how much is energy deficit, how much is dehydration or electrolyte drift, how much is genuinely drug-attributable, and…

78 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
tirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
shareeditfollowflag
NP
askednet_peptide12k1524 Apr 2026

5 Answers

Accepted answer first, then by votes
46

Accepted answer

Take it from the SURPASS-2 adverse-event table by arm, and check the unit before you use it. An incidence can be the proportion of participants who reported the event at least once, or the count of events divided by exposure time, and the two differ by however many people had it repeatedly. Then subtract the placebo arm, because the untreated rate is not zero. And read the discontinuation column beside it: an event that made people leave the trial is under-counted at every later visit, so a low late-timepoint incidence can mean the event was severe rather than rare.

The honest answer is that this is usually fixable by eating more, which is unwelcome advice in this context.

Dehydration from reduced fluid intake alongside reduced food intake produces headache, lethargy and postural dizziness, and is the cheapest thing on the list to correct.

Sleep quality often changes during rapid weight loss in both directions, and sleep debt produces fatigue that no amount of dietary adjustment will fix.

Energy deficits above roughly a thousand kilocalories a day are associated with measurable reductions in resting metabolic rate, spontaneous activity and subjective energy in controlled studies.

The caveat is that fatigue with breathlessness, chest symptoms or sudden onset needs assessment rather than dietary adjustment.

Weigh three days of intake honestly. That answers this most of the time.

edited 3 Jun 2026 by coring_risk — corrected a unit error in the worked example

shareimprove this answerflag
CR
answered · acceptedcoring_risk27k277 May 2026
8This should be linked from the help pages. – b_delacroix 5 months ago
add a comment
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
12

The relevant physiology is that a large deficit reduces both available substrate and spontaneous activity, and the second is often mistaken for the first.

A deficit beyond about a thousand kilocalories a day reliably produces fatigue, reduced training performance and reduced spontaneous movement. With appetite suppressed, deficits of that size arrive by accident rather than by plan.

Hypothyroidism, sleep apnoea, depression and anaemia all present as fatigue and all become more likely rather than less in this population, so attribution to the compound should be a diagnosis of exclusion.

Ferritin as an acute-phase reactant is a recognised limitation and is why it is interpreted alongside an inflammatory marker.

Abrupt onset points away from the deficit and towards something else.

shareimprove this answerflag
SB
answereds_bhattacharya31k3821 Jul 2026
7Same pattern here, and it resolved on the timeline described. – forty_two_c 4 months ago
add a comment
10

The short version: check intake, check hydration, check iron and thyroid if it persists, and only then attribute it to the compound.

Carbohydrate intake specifically affects training performance and perceived energy at a given total intake, which is why very low carbohydrate approaches feel worse in the gym at matched energy.

Three days of honest weighed intake usually settles this. Estimated intake in this situation is systematically wrong and usually wrong in the direction that hides the problem.

Attributing a symptom with a wide differential to the most recent change is a common and expensive error.

Sleep is a variable here too, and no amount of eating fixes sleep debt.

shareimprove this answerflag
DV
answeredDr_Ilse_Vandenberg113k24829 Jun 2026
10

Start with the actual intake, because a substantially suppressed appetite produces deficits far larger than intended and fatigue is the first symptom.

Fatigue that appeared abruptly, rather than gradually with the deficit, is a different pattern and points away from intake.

Sleep restriction produces measurable decrements in subjective energy and in training performance independently of energy intake.

Check fluid and sodium before anything more exotic.

shareimprove this answerflag
AM
answeredaine_mulcahy28k2710 Jul 2026
-3

Mechanically, if it persists at an adequate intake, it needs blood work rather than more speculation.

Iron deficiency is common, particularly in menstruating women, and low intake plus a reduced red-meat share makes it more likely. Ferritin is the test, and it is an acute-phase reactant so it needs interpreting alongside CRP.

Nothing here is medical advice.

If it persists at an adequate intake, get bloods rather than more theories.

shareimprove this answerflag
DV
answeredDr_Ilse_Vandenberg113k24826 Apr 2026
4Worth flagging that this presents differently in people who titrated faster than the label. – Dr_Malik_Osei 4 months ago
5The red-flag list should be higher up the answer, not at the bottom. – fib4_reader 5 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.